Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples